T. A. W. Splinter - Concepedia

Concepedia

Author

T. A. W. Splinter

Rotterdam University of Applied Sciences

Also Known As

T A Splinter, T AW Splinter, T Splinter, T. A. Splinter, T. A. W. Splinter, T. Splinter, T.A.W Splinter, T.A.W. Splinter, TAW Splinter

53

Publications

1.1K

Citations

19

H-Index

38

Concepts

All Affiliations

Rotterdam University of Applied Sciences European Organisation for Research and Treatment of Cancer Centre Hospitalier de Mulhouse Erasmus MC Erasmus University Rotterdam

TA

About

T. A. W. Splinter is an author at Rotterdam University of Applied Sciences specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	854
2	Health Sciences	2	2	231
3	Cell Biology	2	2	88
4	Social Sciences	1	1	18
5	Administrative Law	1	1	18

T. A. W. Splinter

×

24

Publications

1.1K

Citations

19

H-Index

	Year	Citations
Evaluation of a radioimminoassay for neuron specific enolase in small cell lung cancer E H Cooper, T. A. W. Splinter, Dorothy A. Brown, British Journal of Cancer Neuron Specific EnolaseMedicineBronchial NeoplasmRadiopharmaceutical TherapyLung Cancer	1985	121
An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer. J. Wils, Harry Bleiberg, O. Dalesio, Journal of Clinical Oncology Gastrointestinal OncologyMedicineSequential MethotrexatePharmacologyGastroenterology	1986	114
Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1 Ate van der Gaast, CHH Schoenmakers, TC Kok, British Journal of Cancer Non-small-cell Lung CancerCancer DetectionMedicinePathologyBronchial Neoplasm	1994	110
Combination Chemotherapy with Cisplatin and Methotrexate in Advanced Transitional Cell Cancer of the Bladder G. Stoter, T. A. W. Splinter, J. Anthony Child, The Journal of Urology	1987	101
Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres LG Jørgensen, J Genollá, SA Gomm, British Journal of Cancer Prognostic BiomarkersMedicinePathologyBronchial NeoplasmSerum Neuron-specific Enolase	1996	94
The urokinase-type plasminogen activator system in resected non-small-cell lung cancer Martin Salden, T. A. W. Splinter, Harry A. Peters, Annals of Oncology Oncogenic AgentMedicinePathologyBronchial NeoplasmTumor Suppressor	2000	52
Phase II study of epirubicin in advanced adenocarcinoma of the pancreas J. Wils, Harry Bleiberg, G.H. Blijham, European Journal of Cancer and Clinical Oncology OncologyPancreatic CancerGastrointestinal OncologyMedicineAdvanced Adenocarcinoma	1985	50
Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas T. A. W. Splinter, H. Obertop, T.C. Kok, Journal of Cancer Research and Clinical Oncology Surgical OncologyPancreatic CancerMedicineAdjuvant ChemotherapyPancreatic Surgery	1989	49
Acute Antiemetic Efficacy and Safety of Dolasetron Mesylate, A 5-HT3 Antagonist, in Cancer Patients Treated with Cisplatin Thierry Conroy, P Cappelaere, Michel Fabbro, American Journal of Clinical Oncology	1994	37
Neuron-specific enolase (NSE): A useful marker in small cell lung cancer E.H. Cooper, T. A. W. Splinter Lung Cancer Neuron-specific EnolaseTumor BiologyUseful MarkerTumor InnervationPathology	1987	36

Page 1